6-cyclopropyl-2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4,6-di(propan-2-yl)pyridazin-3-one;2-(4-fluorophenyl)-6-methyl-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one
C59H64F4N8O4 — CID 158622225
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-cyclopropyl-2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4,6-di(propan-2-yl)pyridazin-3-one;2-(4-fluorophenyl)-6-methyl-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one
6-cyclopropyl-2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4,6-di(propan-2-yl)pyridazin-3-one;2-(4-fluorophenyl)-6-methyl-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one (PubChem CID 158622225) has the molecular formula C59H64F4N8O4 and a molecular weight of 1025.20 g/mol. Its IUPAC name is 6-cyclopropyl-2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4,6-di(propan-2-yl)pyridazin-3-one;2-(4-fluorophenyl)-6-methyl-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one.
Molecular Properties
| Compound Name | 6-cyclopropyl-2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4,6-di(propan-2-yl)pyridazin-3-one;2-(4-fluorophenyl)-6-methyl-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one |
|---|---|
| PubChem CID | 158622225 |
| Molecular Formula | C59H64F4N8O4 |
| Molecular Weight | 1025.20 g/mol |
| Exact Mass | 1024.50 |
| IUPAC Name | 6-cyclopropyl-2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4,6-di(propan-2-yl)pyridazin-3-one;2-(4-fluorophenyl)-6-methyl-4-propan-2-ylpyridazin-3-one;2-(4-fluorophenyl)-4-propan-2-ylpyridazin-3-one |
| SMILES | CC(C)c1cc(C(C)C)c(=O)n(-c2ccc(F)cc2)n1.CC(C)c1cc(C2CC2)nn(-c2ccc(F)cc2)c1=O.CC(C)c1ccnn(-c2ccc(F)cc2)c1=O.Cc1cc(C(C)C)c(=O)n(-c2ccc(F)cc2)n1 |
| InChI | InChI=1S/C16H17FN2O.C16H19FN2O.C14H15FN2O.C13H13FN2O/c1-10(2)14-9-15(11-3-4-11)18-19(16(14)20)13-7-5-12(17)6-8-13;1-10(2)14-9-15(11(3)4)18-19(16(14)20)13-7-5-12(17)6-8-13;1-9(2)13-8-10(3)16-17(14(13)18)12-6-4-11(15)5-7-12;1-9(2)12-7-8-15-16(13(12)17)11-5-3-10(14)4-6-11/h5-11H,3-4H2,1-2H3;5-11H,1-4H3;4-9H,1-3H3;3-9H,1-2H3 |
| InChIKey | HYDKXKLIUIACHP-UHFFFAOYSA-N |
| XLogP | 12.29 |
| TPSA | 139.56 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 75 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1025.20 |
| LogP ≤ 5 | 12.29 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158622225 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.